Intelligence Profile
Research Papers
Research on USC-Exos, exosomes from urine-derived stem cells, focuses on their therapeutic potential in various medical conditions.
One paper examines the role of exosomal miR-26a-5p from USC-Exos in reducing renal fibrosis by targeting NRAS, publishing findings in the FASEB journal in 2026. This suggests their potential in kidney disease treatment.
Another study published in Theranostics in 2026 explores USC-Exos in combination with 3D-printed scaffolds for promoting alveolar bone regeneration, indicating benefits through energy metabolism regulation.
A 2024 meta-analysis in Frontiers in Pharmacology investigates stem cell-derived exosomes for treating ischemic stroke in animal models, providing a broader look at therapeutic applications beyond USC-Exos alone.
Additionally, USC-Exos show promise in treating temporomandibular joint osteoarthritis, with findings detailed in the FASEB journal in 2024, suggesting possible applications in joint health.
The journal Biomaterials Research in 2024 reports on the miR-122-5p/SOX2 axis's role in reducing fibrosis and inflammation in obstructive kidney injury, showcasing another angle of USC-Exos' renal protective properties.
Further, research in Chemico-biological interactions in 2024 highlights the potential of USC-Exos for inhibiting pyroptosis, a type of cell death, thereby improving outcomes in ischemia-reperfusion kidney injury.
In orthopaedics, USC-Exos combined with an adhesive hydrogel have been shown to facilitate rotator cuff healing, as published in the Journal of Orthopaedic Translation in 2023, offering insights into their regenerative capabilities.
Research in Materials Today. Bio (2023) demonstrates that USC-Exos delivered via gel hydrogels can accelerate bone regeneration, emphasizing their viability for bone health.
Clinical trials also explore USC-Exos' applications. A completed trial (NCT07495176) investigates their use in corpus spongiosum reconstruction for hypospadias. Another trial (NCT07707505), pending recruitment, compares intracavernosal exosomes to rectal ozone for erectile dysfunction treatment post-prostate surgery.
Disclaimer: This summary is for informational purposes only and not a substitute for professional medical advice.